Fulcrum Therapeutics, Inc. (FULC)
3.77
+0.07
(+1.89%)
USD |
NASDAQ |
Oct 28, 16:00
3.77
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Price to Book Value : 0.9257 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 0.9085 |
| October 26, 2026 | 0.8937 |
| October 23, 2026 | 0.9035 |
| October 22, 2026 | 0.9035 |
| October 21, 2026 | 0.9085 |
| October 20, 2026 | 0.9134 |
| October 19, 2026 | 0.9085 |
| October 16, 2026 | 0.8962 |
| October 15, 2026 | 0.9011 |
| October 14, 2026 | 0.9011 |
| October 13, 2026 | 0.9035 |
| October 12, 2026 | 0.9207 |
| October 09, 2026 | 0.9256 |
| October 08, 2026 | 0.9207 |
| October 07, 2026 | 0.9011 |
| October 06, 2026 | 0.906 |
| October 05, 2026 | 0.9109 |
| October 02, 2026 | 0.906 |
| October 01, 2026 | 0.9035 |
| September 30, 2026 | 0.9085 |
| September 29, 2026 | 0.9085 |
| September 28, 2026 | 0.9134 |
| September 25, 2026 | 0.9183 |
| September 24, 2026 | 0.9293 |
| September 23, 2026 | 0.9355 |
| Date | Value |
|---|---|
| September 22, 2026 | 0.9428 |
| September 21, 2026 | 0.933 |
| September 18, 2026 | 0.9232 |
| September 17, 2026 | 0.9256 |
| September 16, 2026 | 0.9306 |
| September 15, 2026 | 0.9281 |
| September 14, 2026 | 0.9306 |
| September 11, 2026 | 0.933 |
| September 10, 2026 | 0.933 |
| September 09, 2026 | 0.9428 |
| September 08, 2026 | 0.9379 |
| September 04, 2026 | 0.9453 |
| September 03, 2026 | 0.9428 |
| September 02, 2026 | 0.9453 |
| September 01, 2026 | 0.9502 |
| August 31, 2026 | 0.9551 |
| August 28, 2026 | 0.9453 |
| August 27, 2026 | 0.9453 |
| August 26, 2026 | 0.9477 |
| August 25, 2026 | 0.9477 |
| August 24, 2026 | 0.9428 |
| August 21, 2026 | 0.9404 |
| August 20, 2026 | 0.9453 |
| August 19, 2026 | 0.96 |
| August 18, 2026 | 0.9502 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 13.21 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8816 |
| Definium Therapeutics, Inc. | 5.572 |
| LeonaBio, Inc. | 1.416 |
Price to Book Value Related Metrics
| Price | 3.77 |
| Earnings Yield | -32.18% |
| Market Cap | 287.60M |